Milestone Pharmaceuticals Inc., a Montreal-based cardiovascular drug development company, has raised $13 million in fresh capital. Pappas Ventures, the Business Development Bank of Canada and GO Capital co-led the round. Fonds de solidarité FTQ, iNovia Healthcare Ventures and Fonds Bio-Innovation also participated. The money will be used for continued development. As a result of the round, Eric Linsley, managing partner of Pappas Ventures; Scott Weiner, senior principal at Pappas Ventures; and Dominic Jaikaran, principal at BDC Health Venture Fund, will join Milestone’s board.
This week marks the one-year anniversary of Facebook’s public offering, one of the most highly anticipated market events in Wall
Author : connieloizos
Long before taking the helm as CEO of Twitter, Dick Costolo was an aspiring comic at Chicago’s famed The Second
Author : joanna
(Reuters) – High-end sportswear brand Vince is close to filing for an initial public offering, according to two sources close
Author : reuters-news
EnCap Flatrock has invested $200 milllion in Cardinal Midstream. Cardinal Midstream is an oil producer in Dallas. Also, Mark Ward
Author : lbeltran
The National Venture Capital Association has elected Josh Green to serve as its 2013-2014 chairman of the board of directors.
Author : idorbian
Welcome! Join the peHUB community to make connections, share your opinion, and follow your favorite authors. It's quick and easy.
Click here to get started!
ACTIVE COMMUNITY MEMBERS
Aspen Aerogels, Inc. said it raised $22.5 million in a convertible note financing and has decided not to pursue an initial public offering. The company said it will withdraw its S-1 registration statement.The new […]
sister magazine Buyouts is reporting the two biggest NY State pensions are both expanding their private equity staffs
Yesterday, Tableau raised $254.2 […]
active 1 day, 15 hours ago
active 3 weeks, 3 days ago
active 3 weeks, 5 days ago